| 000 | 01894 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250514162056.0 | ||
| 264 | 0 | _c20040116 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchiffer, Ilka B | |
| 245 | 0 | 0 |
_aSwitching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission. _h[electronic resource] |
| 260 |
_bCancer research _cNov 2003 |
||
| 300 |
_a7221-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xphysiology |
| 650 | 0 | 4 |
_aCell Cycle _xphysiology |
| 650 | 0 | 4 |
_aCell Division _xphysiology |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNIH 3T3 Cells |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _xgenetics |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTetracycline _xpharmacology |
| 650 | 0 | 4 |
_aTetracyclines _xpharmacology |
| 700 | 1 | _aGebhard, Susanne | |
| 700 | 1 | _aHeimerdinger, Carolin K | |
| 700 | 1 | _aHeling, Annette | |
| 700 | 1 | _aHast, Jochem | |
| 700 | 1 | _aWollscheid, Ursula | |
| 700 | 1 | _aSeliger, Barbara | |
| 700 | 1 | _aTanner, Berno | |
| 700 | 1 | _aGilbert, Sandra | |
| 700 | 1 | _aBeckers, Thomas | |
| 700 | 1 | _aBaasner, Silke | |
| 700 | 1 | _aBrenner, Walburgis | |
| 700 | 1 | _aSpangenberg, Christian | |
| 700 | 1 | _aPrawitt, Dirk | |
| 700 | 1 | _aTrost, Tatjana | |
| 700 | 1 | _aSchreiber, Wolfgang G | |
| 700 | 1 | _aZabel, Bernhard | |
| 700 | 1 | _aThelen, Manfred | |
| 700 | 1 | _aLehr, Hans-Anton | |
| 700 | 1 | _aOesch, Franz | |
| 700 | 1 | _aHengstler, Jan G | |
| 773 | 0 |
_tCancer research _gvol. 63 _gno. 21 _gp. 7221-31 |
|
| 999 |
_c14349811 _d14349811 |
||